News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2022.04.25
Notice of a Contract Agreement with a Major Japanese Pharmaceutical Company for DDS Drug Development
(122KB)
-
2022.01.21
Announcement of the Start of Early stage Phase II Clinical Trial of PC-SOD
(145KB)
-
2021.12.20
The 20th Semiannual Securities Report has been submitted.
(429KB)
-
2021.11.01
Publication of an article in conversation with Ms. Hiroko Mizushima, founder of the company
(140KB)
-
2021.10.21
Notice of Results of Late stage Phase II Clinical Trial of LT-5001
(129KB)
-
2021.07.28
Request for Notification of Change of Address and Other Changes in Registered Matters of Shareholders
(118KB)
-
2021.07.15
Nikkei Biotech Article Published
(119KB)
-
2021.06.29
Notice of Resolutions of the 19th Ordinary General Meeting of Shareholders.
(89KB)
-
2021.06.24
Notice of Discontinuation of Late stage Phase II Clinical Trial of LT-5001
(126KB)
-
2021.05.24
Notice of Patent Application for LT-1001 (PC-SOD) New Indication
(145KB)
